Cost-effectiveness analysis of double low-dose budesonide and low-dose budesonide plus montelukast among pediatric patients with persistent asthma receiving Step 3 treatment in China-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of double low-dose budesonide and low-dose budesonide plus montelukast among pediatric patients with persistent asthma receiving Step 3 treatment in China

Published:2020-10-14 Issue:12 Volume:23 Page:1630-1639
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Wang Xiaoling¹,Fang Honghao²,Shen Kunling¹,Liu Tianyi³,Xie Jipan²,Liu Yuantao⁴,Wu Peibei⁴,Chen Yilin²,Zhong Jia²,Wu Eric²,Zhou Wei⁵,Wu Bin⁶^ORCID

Affiliation:

1. Beijing Children’s Hospital, Capital Medical University, Beijing, China

2. Analysis Group, Inc., Beijing, China

3. AstraZeneca, Beijing, China

4. AstraZeneca, Shanghai, China

5. Peking University Third Hospital, Beijing, China

6. Renji Hospital, Shanghai, China

Funder

AstraZeneca

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2020.1830410

Reference61 articles.

1. Global Initiative for Asthma [Internet]. Global strategy for asthma management and prevention. Updated 2020 [cited 2020 June 4]. Available from: https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-final-_wms.pdf

2. National and regional asthma programmes in Europe

3. Centers for Disease Control and Prevention [Internet]. Asthma. Atlanta (GA): CDC; 2020 [cited 2020 May 15]. Available from: https://www.cdc.gov/nchs/fastats/asthma.htm

4. How does asthma influence the daily life of children? Results of focus group interviews

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness analysis of budesonide/formoterol SMART therapy versus salmeterol/fluticasone plus as-needed SABA among patients ≥12 years with moderate asthma from the Chinese societal perspective;Journal of Medical Economics;2024-08-17

2. Disparity of the Treatment of Unresectable Non-small Cell Lung Cancer Regarding Chemotherapy: A Systematic Review and Meta-Analysis;Cureus;2024-05-19

3. Estimating the Economic Impact of Levalbuterol’s Potential Transition From the National Reimbursement Drug List for the Treatment of Pediatric Asthma in China: A Budget Impact Analysis;Cureus;2024-05-19

4. Cost-effectiveness of Arg16Gly in ADRB2 pharmacogenomic-guided treatment for pediatric asthma;Expert Review of Pharmacoeconomics & Outcomes Research;2023-06-05

5. Effect of Huangqi Granules Combined with Budesonide on Clinical Indexes, Clinical Efficacy, and Safety in Children with Bronchial Asthma;CURRENT TOPICS IN NUTRACEUTICAL RESEARCH;2023-04-07